Feed aggregator

vTv Slashes 65% of Workforce to Push Diabetes Program through Phase III

Biospace news - Tue, 12/07/2021 - 02:00
​vTv Therapeutics said that the funds it saves through this process will allow it to focus on the Phase III development of TP399 and the company's future growth.

Ionis and AstraZeneca Team Up on Antisense Drug for ATTR

Biospace news - Tue, 12/07/2021 - 02:00
Ionis will manufacture and supply the drug for ongoing trials and process qualifications, while AstraZeneca will handle the commercial supply of eplontersen.

WHO Issues Guidance Against Convalescent Plasma for COVID-19

Biospace news - Tue, 12/07/2021 - 02:00
The WHO's latest decision is based on advice from an independent panel of experts who evaluated data from 16 randomized controlled studies.

Traversing the Wnt Pathway with Intellectual Curiosity and Collaboration

Biospace news - Tue, 12/07/2021 - 02:00
Surrozen's ethos is “CLIMB ON”. This catchy and focus-appropriate acronym stands for Collaborate, Lead, Innovate, Motivate and be Brave, Open and Nurturing.

Engrafting Bacteria for Therapeutic Advantage in Kidney-Related Diseases

Biospace news - Tue, 12/07/2021 - 02:00
Proof of concept for the Genetically Engineered Microbial Medicines (GEMM) platform came in a recent first-in-human, Phase I trial.

Top 12 Biotech Companies Hiring Now

Biospace news - Tue, 12/07/2021 - 02:00
Life sciences professionals are mixed as to whether the job market is in favor of the candidate or the employer. However, life sciences employers aren’t.

Bayer Looks to Prostate Cancer Drug for Next Blockbuster

Biospace news - Fri, 12/03/2021 - 02:00
Bayer has high hopes of driving its prostate cancer drug into blockbuster status, meaning over $1 billion in annual sales. This week's ARASENS trial results should help pave the road.

Former Immunomedics CFO Charged with Insider Trading

Biospace news - Fri, 12/03/2021 - 02:00
The SEC announced charges against Usama Malik and his former live-in girlfriend Lauren S. Wood regarding an FDA decision during a trading black out.

Lilly’s Monoclonal Antibody Combo Wins EUA for Patients Under Age 12

Biospace news - Fri, 12/03/2021 - 02:00
This afternoon, the U.S. Food and Drug Administration expanded the Emergency Use Authorization for Eli Lilly’s monoclonal antibody treatment combination of bamlanivimab and etesevimab.

Study: Adenovirus Could be Cause of Rare Blood Clots in AstraZeneca Vaccine

Biospace news - Fri, 12/03/2021 - 02:00
​Scientists from Cardiff University and the Arizona State University believe they have found the likely cause of blood clotting in some recipients of the Oxford-AstraZeneca COVID-19 vaccine.

Embryo-Like Model Could Advance Research in Early Human Development

Biospace news - Fri, 12/03/2021 - 02:00
​Called "iBlastoids," the alternative embryo-like structures are grown for up to 13 days in the lab for use in different types of studies on the behavior of human embryos.

In Head-to-Head Comparison, Moderna Bests Pfizer by a Nose

Biospace news - Fri, 12/03/2021 - 02:00
Researchers from Harvard University and the U.S. Department of Veterans Affairs (VA) found that the Moderna mRNA vaccine was slightly better than the Pfizer-BioNTech vaccine.

"Fourth Wave" Driven Primarily by Delta and New Omicron Data

Biospace news - Fri, 12/03/2021 - 02:00
Two years into the COVID-19 pandemic, countries are reporting the fourth wave of rising cases, driven mainly by the Delta variant, although Omicron has everybody concerned. Here’s a look.

Research Roundup: A Potential Cause of Alzheimer’s Disease and More

Biospace news - Fri, 12/03/2021 - 02:00
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

Mix-and-Match Vaccine Platform May Boost Immune Response & Duration

Biospace news - Fri, 12/03/2021 - 02:00
IDRI is working with a newly-formed consortium to develop a next-gen COVID-19 vaccine that will be stable at routine temperatures and that may be able to confer immunity for a longer duration.

BioSpace Movers & Shakers, Dec. 3

Biospace news - Fri, 12/03/2021 - 02:00
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

Novartis Inks Potential $1.5 Billion Parkinson's Deal with UCB

Biospace news - Thu, 12/02/2021 - 02:00
Novartis held an investor event to discuss their research programs, highlighting its partnership with Belgian pharma company UCB worth up to $1.5 billion.

Astellas Hopes to Improve Gene Therapy Safety with $1.6 Billion Dyno Deal

Biospace news - Thu, 12/02/2021 - 02:00
With this new collaboration, Astellas will take advantage of Dynos' next-gen AAV vectors to deliver its gene therapy.

Study: Survivors of Severe COVID-19 at Higher Mortality Risk and More Research

Biospace news - Thu, 12/02/2021 - 02:00
Research continues to reveal how COVID-19 affects different people with different health issues, both short-term and long-term.

Amgen's Otezla Shines Again in Psoriasis

Biospace news - Thu, 12/02/2021 - 02:00
​The Phase III DISCREET study evaluated the efficacy of Otezla (apremilast) in adults who have been diagnosed with moderate to severe plaque psoriasis and moderate to severe genital psoriasis.